Pfizer, BioNTech: COVID-19 Vaccine ‘90% Effective’ In Phase 3 Trial
COVID-19 vaccine was “90% effective” in Phase 3 trial, according to Pfizer and BioNTech. Pfizer and BioNTech on Monday announced that a jointly-developed COVID-19 vaccine was “90% effective” in ongoing Phase 3 trials. This, as the joint statement from Pfizer and BioNTech was released on Pfizer’s website as soaring COVID-19 cases across the world had … Read more